Edit

Stay Connected

1st Meeting Of The Saudi Society For Oncology Research (DAEM)

SSOR - 2022

Hybrid Event

1-2 September, 2022

Sheraton Hotel- Dammam

Welcome Messages

 

On behalf of the board members and the organizing committee, we would like to welcome you to join us at our 1st meeting in the Saudi Society of Oncology Research (DAEM), which will be held in Sheraton’s Hotel in Dammam, on September 1st, 2022.
Tremendous efforts have been made in the field of cancer research that impressively transformed the current therapeutic landscape of managing cancer. This is evidence of improved survival rates across different cancer subtypes. These phenomenal achievements wouldn’t have been possible without the collaborative inputs of researchers at the bed and bench sides, and this is where DAEM comes into play and can contribute.
This meeting will be the 1st meeting for the society to bring all to the table. It consists of 3 different sessions along with a poster session and a series of workshops that have been carefully selected to serve the needs of the community in the kingdom.
We are beyond grateful to all organizing members, sponsors, our guest speakers, and all attendees for being the basis of the meeting’s success.

 

Dr. Abdulaziz Almotlak, MS, PhD
Saudi Society for Oncology Research president

 

Dear colleagues

I am honored and delighted to welcome you all to the 1 st meeting of the Saudi Society for oncology
Research SSOR-2022 that going to be held during September 1-2 at Dammam, Saudi Arabia
I am highly optimistic that the scientific program of the SSOR-2022 will pave the way to gather
scientific visionaries through the inspiring and scientific talks and presentations, and will also put
forward many thought-provoking strategies for future lines of action in the area of oncology research.
This event will discuss the progress and challenges of cancer research in Saudi Arabia in the
first day. However, the workshop on the second day will cover very specialized and advanced topics
in order to improve the research methodology in the area of cancer research.
I sincerely hope that this conference will deliberate on various issues that need to be addressed in
oncology research and come up with recommendations that will lead to sustainably increasing the
oncology research studies without any obstacles.
I am looking forward to meeting all of you at SSOR-2022 to make our initiatives of disseminating
knowledge in cancer research achieves a grand success.

Dr. Kholoud Alwosaibai
Vice President and Executive Director for the Saudi Society for Oncology Research

Topics

  • Cancer research at Saudi Arabia.
  • Why do we need to do Cancer research?
  • Precision medicine in cancer.
  • Advanced research topics in cancer epidemiology.
  • Advanced research topics in cancer clinical trail
  • Advanced research topics in cancer genetics.

Workshops

  • Innovative Approaches in Cancer Research
  • Clinical Research Methodology

Target Audience​

  • Cancer Researchers
  • Physicians
  • Medical and postgrad students
  • Cancer survivals
  • Pharma and Life science Companies.
  • Physicians And Oncologists

Numbers

0
participants
0
speakers
0
workshops
0
exhibitors

Agenda

8:30 am - 9:00 am

Registration

Poster session

9:00 am - 9:10 am

Opening ceremony and brief on DAEM Society

9:10 am - 9:20 am

DAEM initiatives; support today, cure tomorrow

9:20 am - 9:40 am

Opening ceremony and Signing agreements

9:40 am - 9:55 am

Why cancer research is important to treat our patients?

9:55 am - 10:10 am

Oncology research as a priority for Saudi NIH

10:10 am - 10:25 am

SFDA's roles in evaluating clinical trials and oncology drugs

10:25 am - 10:40 am

The importance of cancer research; personalized medicine as the way to go

10:40 am - 10:50 pm

Panel Discussion

Cancer Research Challenges at KSA

10:50 am - 11:05 am

Localizing cancer drug industry; current states and future trends

11:05 am - 11:20 am

Saudi Cancer Association efforts in advancing community knowledge about cancer

11:20 am - 11:35 am

SNAD association and cancer research

11:35 am - 11:50 am

Scientific societies contribution on enhancing cancer patient care: the role of the Saudi Oncology Society

11:50 am - 12:00 pm

Panel Discussion

12:00 pm - 1:00 pm

Lunch & Prayer

1:00 pm - 1:15 pm

Clinical trials and Cancer Research at KSA

1:15 pm - 1:30 pm

Challenges in Cancer Clinical studies

1:30 pm - 1:45 pm

Novel breast cancer genetic mutations in Saudi Population

1:45 pm - 2:00 pm

Cancer Epidemiology at Saudi Arabia

2:00 pm - 2:15 pm

Cancer epidemiology: what, why and how?

2:15 pm - 2:30 pm

The new multi-omics approaches in cancer research

2:45 pm - 3:00 pm

Immunotherapy as an innovative approach to treat cancer

2:45 pm - 3:00 pm

Cancer Immunotherapy: Its History and Possible Future

3:00 pm - 3:30 pm

Selected oral presentations

TBA

3:30 pm - 4:00 pm

Panel Discussion

1:00 pm - 2:00 pm

Navigating publicly available cancer genomic databases: an ocean of data that is a click away!

- Understand the principles of cancer genetics that influence cancer etiology and prognosis
- Explore publicly available cancer genomic databases
- Generate secondary cancer genomic data addressing your research questions.

2:00 pm - 3:00 pm

How to use In-silico drug design and discovery methods in cancer research?

- Provide a brief overview of computer-aided drug design (CADD) and its role in the drug discovery and development process with a review of some successful examples of anti-cancer drug discoveries that were using computational methods.
- Discuss the main computational drug design approaches in the drug discovery process with a focus on anti-cancer drugs discovery.
- Outline up-to-date drug discovery tools and software used to perform the computational drug design strategies.

3:00 pm - 4:00 pm

How to use AI in cancer research

4:00 pm - 5:00 pm

A practical approach to radiomics in cancer research

- To list some applications of radiomics in cancer research.
- To develop a practical plan for a Radiomic Study.
- To discuss a radiomic workflow overview.
- To employ methods from image acquisition to model building.
- To choose a software to start your project.
- To discuss challenges and future directions.

5:00 pm - 7:00 pm

How to use R programming in your research

- Getting started with R and RStudio
- Understand variables, loops, and data structures
- Manipulate research data structures
- Apply statistical programming and other functions

1:00 pm - 2:00 pm

Unravelling the complexity of cancer

By the end of this lecture, participants should be able to:

- Describe the hallmarks of cancer
- Explain the complex biology of the Tumor Microenvironment (TME)
- Discuss the rationale of combination cancer therapy
- Illustrate how advanced technologies could help unravel the complex biology of cancer

2:00 pm - 3:00 pm

Observational studies & How to design it

- Identify basic epidemiologic observational study designs
- Recognize their basic components
- Recognize their statistical measures of association
- Understand the advantages and limitations of each study design

3:00 pm - 4:00 pm

How to get IRB approval

- Brief IRB history.
- Types of IRB reviews.
- Application process.
- Insiders tips and take home message.

4:00 pm - 5:00 pm

Data Management: prior to collection and beyond analysis

Objectives: - Overview of data management - Importance of data management plan - Data collection methods and sources - Data handling, quality check and storage

5:00 pm - 6:00 pm

Introduction to statistics in clinical trials


- Introduction to statistics in clinical trials
- Reporting results in clinical trials
- Main concerns in statistics of clinical trials

ticket

Ticket pricing

FAQ

  • Price Vat Inclusive
  • Make Sure That the Email Used for Registration Is Valid
  • We Prefer to Use Private Email Not a Business Email
  • Price is not returnable after the events begins
  • Physical Attendance: ID card will be sent 48 hours for printing to attend the Event
  • Online Attendance: Virtual attending link will be sent 24 hours before the Event
  • Make Sure that You Added Your Saudi Commission for Health Specialties Number correctly
  • CME is currently under process
  • CME Will be added in your mumaris, two weeks after the conference ends
  • CME will be added to the below target Audience only
  • Cancer Researchers
  • Physicians
  • Medical and postgrad students
  • Cancer survivals
  • Pharma and Life science Companies.
  • Physicians And Oncologists
× How can I help you?